This inventor holds 2 USPTO granted patents. Top assignee: Fujian Medical University. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fuzhou, CN (2015)
- Fujian Province, CN (2024)
Company Filing History:
Years Active: 2015-2024
Title: Ying Xu: Innovator in Medicinal Chemistry
Introduction
Ying Xu is a prominent inventor based in Fuzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for inflammatory and autoimmune diseases. With a total of 2 patents, his work focuses on the therapeutic applications of koumine, an alkaloid monomer.
Latest Patents
Ying Xu's latest patents include innovative uses of koumine in the preparation of medicaments. The first patent details the use of koumine for the treatment of inflammatory bowel disease. This invention highlights the novel application of koumine or its pharmaceutically acceptable salts in creating effective medications for this condition. The second patent discusses the use of koumine and its homologues in treating autoimmune diseases affecting bones and joints. This patent emphasizes koumine's potential to reduce the generation of antibodies against such diseases, improve symptoms, and reverse joint pathological changes, showcasing its strong potency and low toxicity.
Career Highlights
Ying Xu is affiliated with Fujian Medical University, where he continues to advance research in medicinal chemistry. His work has garnered attention for its potential industrial applications, particularly in developing new drugs for autoimmune diseases like rheumatoid arthritis and ankylosing spondylitis.
Collaborations
Ying Xu collaborates with notable colleagues, including Jian Yang and Changxi Yu, who contribute to his research endeavors and innovations in the field.
Conclusion
Ying Xu's contributions to medicinal chemistry, particularly through his patents on koumine, demonstrate his commitment to advancing healthcare solutions. His work holds promise for developing effective treatments for inflammatory and autoimmune diseases, marking him as a significant figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile